Taysha Gene Therapies, Inc. (TSHA) revenue

Revenue · fiscal 2025
$9.77M

Taysha Gene Therapies, Inc. (TSHA) reported revenue of $9.77M in fiscal 2025 (the year ended December 31, 2025). That is 17.3% higher than the $8.33M of fiscal 2024. Figures as of 18 Nov 2026, 07:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$9.77M
Change on fiscal 2024
+17.3%
Highest on record
$15.45Mfiscal 2023
Lowest on record
$2.50Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Taysha Gene Therapies, Inc. revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $15.45M in fiscal 2023 and the lowest $2.50M in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Taysha Gene Therapies, Inc. revenue, year by year

Taysha Gene Therapies, Inc. (TSHA) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$9.77M 17.3% up
2024$8.33M 46.1% down
2023$15.45M 517.5% up
2022$2.50M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on TSHA

Taysha Gene Therapies, Inc., figure by figure

Taysha Gene Therapies, Inc. (TSHA) overview: price, valuation and scorecard

Taysha Gene Therapies, Inc. revenue: questions and answers

What is Taysha Gene Therapies, Inc.'s revenue?

Taysha Gene Therapies, Inc. (TSHA) reported revenue of $9.77M in fiscal 2025 (the year ended December 31, 2025). That is 17.3% higher than the $8.33M of fiscal 2024.

What are the highest and lowest revenue figures on record for Taysha Gene Therapies, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $15.45M in fiscal 2023 and the lowest $2.50M in fiscal 2022.

How is Taysha Gene Therapies, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Taysha Gene Therapies, Inc. (TSHA) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/TSHA/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.